History of meningococcal vaccines and their serological correlates of protection

被引：52

作者：

Vipond, Caroline ^{[1
]}

Care, Rory ^{[1
]}

Feavers, Ian M. ^{[1
]}

机构：

[1] NIBSC, Div Bacteriol, Potters Bar EN6 3QG, Herts, England

来源：

VACCINE | 2012年 / 30卷

关键词：

Vaccine; Meningitis; Polysaccharide; Outer membrane vesicle; Serological correlate; Complement; Bactericidal antibody; Gene expression; OUTER-MEMBRANE PROTEIN; C CONJUGATE VACCINE; MENINGITIDIS GROUP-B; FACTOR-H BINDING; NEISSERIA-MENINGITIDIS; SEROGROUP-C; GROUP-A; IMMUNE-RESPONSE; VESICLE VACCINE; POLYSACCHARIDE VACCINE;

D O I：

10.1016/j.vaccine.2011.12.060

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

For over a hundred years Neisseria meningitidis has been known to be one of the major causes of bacterial meningitis. However, effective vaccines were not developed until the latter part of the 20th century. The first of these were based on purified high molecular weight capsular polysaccharides and more recently the development of glycoconjugate vaccines has made paediatric immunisation programmes possible. The prevention of group B meningococcal disease has remained a challenge throughout this period. This review charts the history of the development of meningococcal vaccines and the importance of serological correlates of protection in their evaluation. (C) 2012 Elsevier Ltd. All rights reserved.

引用

页码：B10 / B17

页数：8

共 125 条

[21] Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines [J].

Donnelly, John ;

Medini, Duccio ;

Boccadifuoco, Giuseppe ;

Biolchi, Alessia ;

Ward, Joel ;

Frasch, Carl ;

Moxon, E. Richard ;

Stella, Maria ;

Comanducci, Maurizio ;

Bambini, Stefania ;

Muzzi, Alessandro ;

Andrews, William ;

Chen, Jie ;

Santos, George ;

Santini, Laura ;

Boucher, Philip ;

Serruto, Davide ;

Pizza, Mariagrazia ;

Rappuoli, Rino ;

Giuliani, Marzia Monica .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (45) :19490-19495

[22]

Eskola Juhani, 1993, Current Opinion in Pediatrics, V5, P55, DOI 10.1097/00008480-199302000-00009

[23] Persisting immune responses indicating long-term protection after booster dose with meningococcal group B outer membrane vesicle vaccine [J].

Feiring, Berit ;

Fuglesang, Jan ;

Oster, Philipp ;

Naess, Lisbeth M. ;

Helland, Oddveig S. ;

Tilman, Sandrine ;

Rosenqvist, Einar ;

Bergsaker, Marianne A. R. ;

Nokleby, Hanne ;

Aaberge, Ingeborg S. .

CLINICAL AND VACCINE IMMUNOLOGY, 2006, 13 (07) :790-796

[24] Immunization of human subjects with the specific carbohydrates of Type III and the related Type VIII pneumococcus [J].

Finland, M ;

Ruegsegger, JM .

JOURNAL OF CLINICAL INVESTIGATION, 1935, 14 (06) :829-832

[25]

Finland M, 1935, J IMMUNOL, V29, P285

[26]

FINNE J, 1983, LANCET, V2, P355

[27] POLYSIALIC ACID - A GLYCOPROTEIN CARBOHYDRATE INVOLVED IN NEURAL ADHESION AND BACTERIAL-MENINGITIS [J].

FINNE, J .

TRENDS IN BIOCHEMICAL SCIENCES, 1985, 10 (03) :129-132

[28] Vaccine potential of the Neisseria meningitidis 2086 lipoprotein [J].

Fletcher, LD ;

Bernfield, L ;

Barniak, V ;

Farley, JE ;

Howell, A ;

Knauf, M ;

Ooi, P ;

Smith, RP ;

Weise, P ;

Wetherell, M ;

Xie, XL ;

Zagursky, R ;

Zhang, Y ;

Zlotnick, GW .

INFECTION AND IMMUNITY, 2004, 72 (04) :2088-2100

[29]

FRANCIS THOMAS, 1930, JOUR EXP MED, V52, P573, DOI 10.1084/jem.52.4.573

[30] PROTECTION AGAINST GROUP-B MENINGOCOCCAL DISEASE .1. COMPARISON OF GROUP-SPECIFIC AND TYPE-SPECIFIC PROTECTION IN CHICK-EMBRYO MODEL [J].

FRASCH, CE ;

PARKES, L ;

MCNELIS, RM ;

GOTSCHLICH, EC .

JOURNAL OF EXPERIMENTAL MEDICINE, 1976, 144 (02) :319-329

← 1 2 3 4 5 6 7 8 9 10 →